4.2 Review

Thrombotic thrombocytopenic purpura: A thrombotic disorder caused by ADAMTS 13 deficiency

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 21, Issue 4, Pages 609-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2007.06.003

Keywords

-

Funding

  1. NHLBI NIH HHS [R01 HL062136-08, HL62136, R01 HL062136] Funding Source: Medline

Ask authors/readers for more resources

A serious disorder with characteristic microvascular thrombosis involving the brain and other organs, thrombotic thrombocytopenic purpura (TTP) typically presents with thrombocytopenia, hemolysis with schistocytes on blood smears, and mental changes or seizures. It may progress rapidly to a fatal end if the patient is not treated immediately with plasma. Recent advances have shown that TTP is caused by deficiency of a circulating, von Willebrand factor cleaving metalloprotease, ADAMTS13. This new knowledge will provide clues to improve the diagnosis and management of this intriguing disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available